Pubblicazioni Scientifiche

Selezione dei principali lavori scientifici scritti in qualità di autori o coautori in collaborazione con altri (non citati per motivi di spazio), distinti in base all’argomento (NB: non rispettato l’ordine degli autori)

Psoriasi
  • Vena GA & Cassano N, in collaborazione con altri autori. Survival rate of anti-TNF-alpha treatments for psoriasis in routine dermatological practice: a multicenter observational study. Br J Dermatol 2013.
  • Vena GA, et al. Etanercept provides an effective, safe and flexible short-and long-term treatment regimen for moderate-to-severe psoriasis: A systematic review of current evidence. J Dermatolog Treat 2013.
  • Vena GA, et al. Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry. J Eur Acad Dermatol Venereol 2013.
  • Cassano N, et al. Detection and management of latent tuberculosis infections before biologic therapy for psoriasis. J Dermatolog Treat 2012.
  • Cassano N, et al. Psodisk, a new visual method for assessing the burden of psoriasis on patients. J Eur Acad Dermatol Venereol 2012.
  • Vena GA, Cassano N, et al. Efficacy of etanercept for the treatment of psoriasis: An overview of the Italian clinical experience from the real-life setting and independent studies. Immunopharmacol Immunotoxicol 2012.
  • Vena GA, et al. Consensus on the use of the fixed combination calcipotriol/betamethasone dipropionate in the treatment of plaque psoriasis. G Ital Dermatol Venereol 2012.
  • Vena GA, Cassano N. Janus kinase inhibition as a potential strategy for the treatment of psoriasis: State of the art and future perspectives. J Biol Regul Homeost Agents 2012.
  • Vena GA, et al. Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: A cost-effectiveness analysis of the ointment versus gel formulation. Clin Econ Outcomes Res 2012.
  • Vena GA, et al. Safety of anti-TNF-alpha agents in the treatment of psoriasis and psoriatic arthritis. Immunopharmacol Immunotoxicol 2012.
  • Vena GA, Cassano N, et al. Combined treatment with low-dose cyclosporine and calcipotriol/ betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: A randomized controlled open-label study. J Dermatolog Treat 2012.
  • Vena GA, Cassano N, et al. Combination of etanercept and twice-weekly administration of cyclosporin in psoriasis unsatisfactorily controlled by etanercept monotherapy: A retrospective analysis. Eur J Inflamm 2012.
  • Vena GA, Cassano, et al. Alcohol, psoriasis, liver disease, and anti-psoriasis drugs. Int J Dermatol 2011.
  • Vena GA, Cassano, et al. Role of serum uric acid in conditioning the association of psoriasis with metabolic syndrome. Eur J Dermatol 2011.
  • Vena GA, et al. Health-related quality of life in psoriasis: An analysis of Psocare project patients. G Ital Dermatol Venereol 2011.
  • Vena GA, Cassano, et al. Anti-tumor necrosis factor treatment in occult hepatitis B virus infection: A retrospective analysis of 62 patients with psoriatic disease. J Biol Regul Homeost Agents 2011.
  • Vena GA, Cassano, et al. Renal function in psoriasis patients. Eur J Dermatol 2011.
  • Vena GA, Cassano N, et al. Influence of infliximab on keratinocyte apoptosis in psoriasis patients. Immunopharmacol Immunotoxicol 2011.
  • Vena GA, Cassano, et al. Adjuvant role of a new emollient cream in patients with palmar and/or plantar psoriasis: A pilot randomized open-label study. G Ital Dermatol Venereol 2010.
  • Vena GA, Cassano, et al. Psoriasis relapse evaluation with week-end cyclosporine A treatment: Results of a randomized, double-blind, multicenter study. Int J Immunopathol Pharmacol 2010.
  • Vena GA, et al. Incidence of psoriasis and association with comorbidities in Italy: A 5-year observational study from a national primary care database. Eur J Dermatol 2010.
  • Vena GA, Cassano, et al. Treatment of psoriasis with different dosage regimens of etanercept: Preliminary results from the Taranta Plastic study group. Int J Immunopathol Pharmacol 2010.
  • Vena GA, et al. Editorial: Psoriatic disease: Concepts and implications. J Eur Acad Dermatol Venereol 2010.
  • Vena GA, et al. An Italian shared dermatological and rheumatological proposal for the use of biological agents in psoriatic disease. J Eur Acad Dermatol Venereol 2010.
  • Vena GA, Cassano, et al. Can early treatment with biologicals modify the natural history of comorbidities? Dermatol Ther 2010.
  • Vena GA, Cassano, et al. Therapeutic hotline: Re-induction may be useful to manage psoriasis relapse during long-term maintenance treatment with infliximab: A retrospective analysis. Dermatol Ther 2010.
  • Vena GA, Cassano, et al. Psoriasis and cardiovascular disease. Dermatol Ther 2010.
  • Vena GA, et al. Evolution of and risk factors for psychological distress in patients with psoriasis: The PSYCHAE study. Int J Immunopathol Pharmacol 2010.
  • Vena GA, et al. Cost-effectiveness analysis of TNF-alpha blockers for the treatment of chronic plaque psoriasis in the perspective of the Italian health-care system. Dermatol Ther 2010.
  • Vena GA, et al. Assessing the impact of efalizumab on nail, scalp and palmoplantar psoriasis and on quality of life: Results from a multicentre, open-label, phase IIIb/IV trial. Arch Drug Inform 2009.
  • Vena GA, Cassano, et al. Anti-NuMA antibodies in a psoriatic patient: Considerations about clinical relevance and effect of infliximab treatment. Immunopharmacol Immunotoxicol 2009.
  • Vena GA, et al. Resistant cases of psoriatic arthritis: How to manage them. J Rheumatol 2009.
  • Vena GA, et al. Risk factors of hypertension, diabetes and obesity in Italian psoriasis patients: A survey on socio-demographic characteristics, smoking habits and alcohol consumption. Eur J Dermatol 2009.
  • Vena GA, Cassano, et al. A multicenter open-label experience on the response on psoriasis to adalimumab and effect of dose escalation in non-responders: The Aphrodite project. Int J Immunopathol Pharmacol 2009.
  • Vena GA, Cassano, et al. Influence of body mass index, comorbidities and prior systemic therapies on the response of psoriasis to adalimumab: An exploratory analysis from the Aphrodite data. J Biol Regul Homeost Agents 2008.
  • Vena GA, et al. Etanercept provides a more physiological approach in the treatment of psoriasis. Dermatol Ther 2008.
  • Vena GA, Cassano. Etanercept treatment in a hemodialysis patient with severe cyclosporine-resistant psoriasis and hepatitis C virus infection. Int J Dermatol 2008.
  • Vena GA, Cassano, et al. Efalizumab in moderate-to-severe plaque psoriasis: A retrospective case series analysis from clinical practice. J Biol Regul Homeost Agents 2008.
  • Vena GA, Cassano, et al. Is there an association between antiphospholipid antibodies and psoriasis? J Biol Regul Homeost Agents 2008.
  • Vena GA, Cassano, et al. Safe use of efalizumab in a psoriasis patient with chronic heart failure due to hypertrophic cardiomyopathy. G Ital Dermatol Venereol 2008.
  • Vena GA, Cassano N. Drug focus: Adalimumab in the treatment of moderate to severe psoriasis. Biologics: Targets and Therapy 2007.
  • Vena GA, et al. Psychological distress and coping strategies in patients with psoriasis: The PSYCHAE study. J Eur Acad Dermatol Venereol 2007.
  • Vena GA, Cassano, et al. Re-induction as a possible alternative modality of dose escalation of infliximab: A prospective evaluation in a small series of psoriatic patients. Int J Immunopathol Pharmacol 2007.
  • Vena GA, Cassano N. Anti-tumor necrosis factor therapies for psoriasis. Exp Rev Dermatol 2007.
  • Vena GA, Cassano N, et al. Treatment of mild to moderate plaque psoriasis with calcitriol ointment applied with or without a dosing device. Eur J Inflamm 2007.
  • Vena GA, Cassano N. Emerging drugs for psoriasis. Exp Opin Emerging Drugs 2006.
  • Vena GA, Cassano N, et al. Sequential treatment of psoriasis with infliximab followed by cyclosporin: Preliminary results of an open-label prospective study. G Ital Dermatol Venereol 2006.
  • Vena GA, Cassano N, et al. Psoriasis exacerbation after a flu-like syndrome during anti-TNF-alpha therapy. Eur J Dermatol 2006.
  • Vena GA, Cassano N, et al. Treatment of psoriasis vulgaris with the two-compound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol. Clin Drug Investig 2006.
  • Vena GA, Cassano N, et al. Once-weekly administration of high-dosage etanercept in patients with plaque psoriasis: Results of a pilot experience (Power study). Int J Immunopathol Pharmacol 2006.
  • Vena GA, et al. Psychopatological status and coping strategies in psoriasis patients: Objectives and methodology of the psoriasis: SurveY for the control of anxiety and dEpression (PSYCHAE) study. G Ital Dermatol Venereol 2005.
  • Vena GA, Cassano N, et al. Evaluation of the efficacy and tolerability of a new intermittent treatment regimen with cyclosporin A in severe psoriasis. G Ital Dermatol Venereol 2005.
  • Vena GA, Cassano N, et al. Treatment of psoriasis vulgaris with calcipotriol betamethasone dipropionate combination followed by calcipotriol and assessment of the adjuvant basic use of urea-based emollients. Eur J Inflamm 2005.
  • Vena GA, Cassano N, et al. Infliximab monotherapy for refractory psoriasis: Preliminary results. Int J Immunopathol Pharmacol 2004.
  • Vena GA, Cassano N, et al. Guidelines for the use of cyclosporin A in psoriasis. state of the art. G Ital Dermatol Venereol 2001.
  • Vena GA, Cassano N, et al. Epidemiological study on psoriasis in Sila's area. Ann Ital Derm Clin Sper 1997.
  • Vena GA, et al. Cyclosporin A in psoriasis: Preservation of efficacy with a spaced regimen. Chron Dermatol 1994.
  • Vena GA, et al. On cell-mediated immune response in psoriatic patients. Acta Derm Venereol 1979.
Orticaria e condizioni correlate
  • Vena GA, Cassano N, et al. Urticaria and angioedema to rubisco allergen in spinach and tomato. Ann Allergy Asthma Immunol 2012.
  • Vena GA, Cassano N, et al. Contact urticaria to raw arugula and parsley. Ann Allergy Asthma Immunol 2011.
  • Vena GA, Cassano N, et al. Orticaria acuta: studio retrospettivo clinico-epidemiologico in 342 pazienti ospedalizzati. It J Primary Care 2011.
  • Vena GA, Cassano N, et al. Orticaria. Linee guida e raccomandazioni SIDeMaST. Pacini Editore SpA, Pisa 2011.
  • Vena GA, et al. Physical urticarias: Classification and diagnosis. Ital J Allergy Clin Immunol 2010
  • Vena GA, Cassano N, et al. An overview of delayed pressure urticaria with special emphasis on pathogenesis and treatment. Dermatol Ther 2009.
  • Vena GA, et al. EAACI/GA2LEN/EDF/WAO guideline: Definition, classification and diagnosis of urticaria. Allergy 2009.
  • Vena GA, et al. EAACI/GALEN/EDF/WAO guideline: Management of urticaria. Allergy 2009.
  • Vena GA, Cassano N, et al. Treatment of acquired cold urticaria with rupatadine. Allergy 2009.
  • Vena GA, Cassano N, et al. Italian position paper on urticaria. G Ital Dermatol Venereol 2009.
  • Vena GA, Cassano N, et al. Acquired and familial cold urticarias. Ann It Derm Allergol Clin Sper 2009.
  • Vena GA, Cassano N, et al. Urticaria due to infectious agents. Ann It Derm Allergol Clin Sper 2008.
  • Vena GA, Cassano N, et al. Cyclosporin in chronic urticaria: State of the art. Ann It Derm Allergol Clin Sper 2007.
  • Vena GA, Cassano N. Orticaria cronica: terapia. In: Ulisse. Viaggio nella dermatologia, 2007.
  • Vena GA, Cassano N. Orticaria cronica: diagnosi. In: Ulisse. Viaggio nella dermatologia, 2007.
  • Vena GA, Cassano N, et al. Cyclosporine in chronic idiopathic urticaria: A double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol 2006.
  • Vena GA, Cassano N, et al. Desloratadine 5 mg once daily improves quality of life in chronic idiopathic urticaria. G Ital Dermatol Venereol 2006.
  • Vena GA, Cassano N, et al. Influence of desloratadine on oxidative stress markers in patients with chronic idiopathic urticaria. Int J Dermatol 2006.
  • Vena GA, et al. EAACI/GA2LEN/EDF guideline: Management of urticaria. Allergy 2006.
  • Vena GA, et al. EAACI/GA2LEN/EDF guideline: Definition, classification and diagnosis of urticaria. Allergy 2006.
  • Vena GA, Cassano N, et al. Clobetasol propionate 0.05% in a novel foam formulation is safe and effective in the short-term treatment of patients with delayed pressure urticaria: A randomized, double-blind, placebo-controlled trial. Br J Dermatol 2006.
  • Vena GA, Cassano N, et al. Angioedema. Ann It Derm Allergol Clin Sper 2006.
  • Vena GA, Cassano Net al. Remission of delayed pressure urticaria after eradication of Blastocystis hominis. Acta Derm Venereol 2005.
  • Vena GA, Cassano N, et al. Low-dose dapsone in chronic idiopathic urticaria: Preliminary results of an open study. Acta Derm Venereol 2005.
  • Vena GA, Cassano N, et al. Does oxidative stress play a role in the pathogenesis of urticarias? Eur J Inflamm 2005.
  • Vena GA, Cassano N, et al. Cholinergic urticaria. Ann It Derm Allergol Clin Sper 2004.
  • Vena GA, Cassano N, et al. Exercise-induced anaphylaxis. Ann It Derm Allergol Clin Sper 2004.
  • Vena GA, Cassano N, et al. Over-expression of Mn-superoxide dismutase as a marker of oxidative stress in lesional skin of chronic idiopathic urticaria. Clin Exp Dermatol 2003.
  • Vena GA, Cassano N, et al. Evaluation of plasmatic markers of oxidative stress in patients with chronic idiopathic urticaria. Ann It Derm Allergol Clin Sper 2003.
  • Vena GA, Cassano N, et al. The role of infections in urticaria. In: Marone G, ed. Clinical Immunology and Allergy in Medicine, JGC Editions, Naples, 2003.
  • Vena GA, Cassano N, et al. Fexofenadine in chronic idiopathic urticaria: A clinical and immunohistochemical evaluation. Int J Immunopathol Pharmacol 2002.
  • Vena GA, Cassano N, et al. Evaluation of inflammatory parameters in physical urticarias and effects of an anti-inflammatory/antiallergic treatment. Int J Dermatol 2002.
  • Vena GA, Cassano N, et al. In vivo anti-inflammatory effects of fexofenadine in chronic idiopathic urticaria. J Eur Acad Dermatol Venereol 2002.
  • Vena GA, Cassano N, et al. Delayed pressure urticaria: Critical overview and update on treatment. Ann It Derm Allergol Clin Sper 2002.
  • Vena GA, Cassano N, et al. Oxidative stress in physical urticarias. Clin Exp Dermatol 2001.
  • Vena GA, Cassano N, et al. Mast-cell phenotype in urticaria. Allergy 2001.
  • Vena GA, Cassano N. Clinica dell’orticaria. Giorn It Allergol Immunol Clin 2000.
  • Vena GA, Cassano N. International symposium on urticaria (allergic? autoimmune? inflammatory?). J Eur Acad Dermatol Venereol 1999.
  • Vena GA, Cassano N, et al. Sequential therapy with nimesulide and ketotifen in delayed pressure urticaria. Acta Derm Venereol 1998.
  • Vena GA, Cassano N, et al. The role of diet in urticaria. Ann It Derm Allergol Clin Sper 1998.
  • Vena GA, Cassano N, et al. Occupational contact urticaria from paprika. Contact Dermatitis 1997.
  • Vena GA, Cassano N, et al. Mast cell subpopulations in chronic idiopathic urticaria. Int J Immunopathol Pharmacol 1997.
  • Vena GA, Cassano N, et al. CD34 expression and chronic idiopathic urticaria. Int J Immunopathol Pharmacol 1997.
  • Vena GA, et al. Etiopathogenesis of urticaria. Ann It Dermatol Clin Sper 1993.
  • Vena GA, et al. Indagine policentrica per la valutazione dell’efficacia clinica della cetirizina nel trattamento delle rinopatie e delle orticarie di origine allergica. J Am Med Ass, Ed. Italiana, 1999.
  • Vena GA, et al. Loratadine in the treatment of chronic urticaria. Chron Dermatol 1990.
Tumori cutanei benigni e maligni, lesioni pretumorali, dermoscopia
  • Vena GA, et al. Three novel human sporadic melanoma cell lines: signaling pathways controlled by MC1R, BRAF and β-catenins. J Biol Regul Homeost Agents 2013.
  • Vena GA, Cassano N, et al. Methyl-aminolevulinate photodynamic therapy for the treatment of erythroplasia of Queyrat in 23 patients. J Dermatolog Treat 2012.
  • Vena GA, Cassano N, et al. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic cheilitis: A retrospective evaluation of 29 patients. G Ital Dermatol Venereol 2012.
  • Vena GA, et al. Italian euromelanoma day screening campaign (2005-2007) and the planning of melanoma screening strategies. Eur J Cancer Prevention 2012.
  • Vena GA, et al. Cheratosi attiniche. Linee guida e raccomandazioni SIDeMaST. Pacini Editore SpA, Pisa 2011.
  • Vena GA, Cassano N, et al. Tumore a cellule granulari del capezzolo: una lesione rara con una localizzazione insolita. Esp Dermatol 2011.
  • Vena GA, Cassano N, et al. Epidemiologia del melanoma cutaneo. In: Quaderni Scientifici. TUTTOSANITÀ, 2011.
  • Vena GA, Cassano N, et al. Molecular characterization of novel melanoma cell lines. J Biol Regul Homeost Agents 2011.
  • Vena GA, Cassano N, et al. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: A retrospective analysis of response in 462 patients. G Ital Dermatol Venereol 2009.
  • Vena GA, et al. Italian guidelines and therapeutic algorithm for actinic keratoses. G Ital Dermatol Venereol 2009.
  • Vena GA, Cassano N, et al. Melanocytic nevus with atypical dermoscopic features at the site of radiodermatitis. Dermatol Surg 2006.
  • Vena GA, Cassano N, et al. Dermoscopic features of cutaneous lymphangioma circumscriptum. Dermatol Surg 2006.
  • Vena GA, Cassano N, et al. Regressing cutaneous malignant melanoma and vitiligo-like depigmentation. Int J Dermatol 2006.
  • Vena GA, Cassano N, et al. Unusual clinical presentation of regression in a congenital melanocytic nevus. Dermatol Surg 2005.
  • Vena GA, Cassano N, et al. Dermoscopic patterns of dermatofibroma. Dermatol Surg 2005.
  • Vena GA, Cassano N, et al. Dermatofibroma: A case report and personal considerations. Dermatol Surg 2004.
  • Vena GA, Cassano N, et al. Lessons on dermoscopy: Pigment network in nonmelanocytic lesions. Dermatol Surg 2004.
  • Vena GA, Cassano N, et al. Lessons on dermoscopy: Malignant melanoma on surgical scar - dermoscopic features. Dermatol Surg 2004.
  • Vena GA, et al. Lymphoblastoid α-interferon in the treatment of mediterranean Kaposi's sarcoma. Chron Dermatol 1997.
  • Vena GA, Cassano N, et al. Mortality for cutaneous melanoma in the city of Potenza from 1915 to 1995. Medit J Surg Med 1996.
  • Vena GA, et al. Angiocheratoma corporis diffusum with normal enzyme activities. G Ital Dermatol Venereol 1992.
  • Vena GA, et al. White sponge nevus. Dermatologia Oggi 1990.
  • Vena GA, et al. Monocyte fc-IgG receptors expression and soluble suppressor factor in skin squamous cell carcinoma. Acta Derm Venereol 1983.
  • Vena GA, et al. T cell subsets and soluble immune response suppressor (SIRS) factor in skin squamous cell carcinoma. Acta Derm Venereol 1983.
  • Vena GA, et al. Valutazione statistica tra diagnosi clinica ed istopatologica nelle neoplasie epiteliali cutanee maligne. Riv Ital Chir Plastica 1982.
  • Vena GA, et al. Cellular immunity in squamous-cell and basal-cell carcinomas. G Ital Dermatol Venereol 1982.
  • Vena GA, et al. T lymphocytes with Fc-IgG receptors in skin cancers. Acta Derm Venereol 1981.
  • Vena GA, et al. Contribution to the study of cell-mediated immunity in basal and squamous cell carcinoma. G Ital Dermatol Venereol 1980.
Reazioni cutanee da farmaco e prurito
  • Vena GA, Cassano N, et al. Eczematous reactions due to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers. Immunopharmacol Immunotoxicol 2013.
  • Vena GA, Cassano N. Toxic drug-induced chronic pruritus. Immunopharmacol Immunotoxicol 2012.
  • Vena GA, Cassano N, et al. Prurito cronico non associato a malattie dermatologiche. Linee guida e raccomandazioni SIDeMaST. Pacini Editore SpA, Pisa 2011.
  • Vena GA, Cassano N, et al. Photodermatitis caused by oral ketoprofen: Two case reports. Contact Dermatitis 2011.
  • Vena GA, Cassano N. Drug-induced psoriasis: Review and update. Ann It Dermatol Allergol Clin Sper 2011.
  • Vena GA, Cassano N, et al. Generalized eczematous dermatitis from imipenem after topical exposure. Dermatitis 2011.
  • Vena GA, Cassano N, et al. Photocontact allergy to arylpropionic acid non-steroidal anti-inflammatory drugs in patients sensitized to fragrance mix I. Contact Dermatitis 2010.
  • Vena GA, Cassano N, et al. Chronic pruritus in the absence of specific skin disease: an update on pathophysiology, diagnosis, and therapy. Am J Clin Dermatol 2010.
  • Vena GA, Cassano N, et al. Drug-induced pemphigus and pemphigoid. Ann It Dermatol Allergol Clin Sper 2010.
  • Vena GA, Cassano N, et al. Hypersensitivity reaction to ranitidine: Description of a case and review of the literature. Immunopharmacol Immunotoxicol 2009.
  • Vena GA, Cassano N, et al. Contact allergy to topical corticosteroids: Update and review on cross-sensitization. Recent Patents Inflamm Allergy Drug Discovery 2009.
  • Vena GA, Cassano N, et al. Allergic contact dermatitis from timolol complicating choroidal melanoma-related glaucoma. Eur J Dermatol 2009.
  • Vena GA, Cassano N, et al. Hypersensitivity reactions to last generation chimeric, humanized and human recombinant monoclonal antibodies for therapeutic use. Curr Pharm Des 2008.
  • Vena GA, Cassano N, et al. Acquagenic urticaria and pruritus. Ann It Dermatol Allergol Clin Sper 2007.
  • Vena GA, Cassano N, et al. Allergic contact dermatitis due to diclofenac applied with iontophoresis. Clin Exp Dermatol 2004.
  • Vena GA, Cassano N, et al. Bullous skin eruption associated with entacapone. Int J Dermatol 2004.
  • Vena GA, Cassano N, et al. Dermatosi da ipersensibilità: Orticaria, eczema da contatto, reazioni cutanee avverse a farmaci. In: Fabrizi G, ed. Dermatologia Pediatrica, Masson, Milano 2003.
  • Vena GA, Cassano N, et al. Evaluation of cross-reactivity between budesonide and desonide. Contact Dermatitis 2002.
  • Vena GA, Cassano N, et al. Più cause per grattarsi. La Pelle 2001.
  • Vena GA, Cassano N, et al. Physiopathology of pruritus. Ann It Dermatol Allergol Clin Sper 2000.
  • Vena GA, Cassano N, et al. Contact allergy to thiocolchicoside. Contact Dermatitis 1997.
  • Vena GA, Cassano N, et al. Antibodies to hepatitis C virus and itching skin disorders. Ann It Dermatol Allergol Clin Sper 1997.
  • Vena GA, Cassano N, et al. Occupational contact allergy to cephalosporins. Contact Dermatitis 1997.
  • Vena GA, et al. Cutaneous reactions to alimentary tract medications: Results of a seven-year surveillance program and review of the literature. Dermatology 1996.
  • Vena GA, Cassano N, et al. Allergia da contatto a conservanti di cosmetici. Cosmetics & Toiletries Ed. Italiana 1996.
  • Vena GA, Cassano N, et al. Studio sulla sensibilizzazione da contatto con resine acriliche. Boll Dermatol Allerg Profes 1996.
  • Vena GA, et al. Occupational contact allergy from cephalosporins. Contact Dermatitis 1994.
  • Vena GA, et al. Iatrogenic contact dermatitis and eczematous reactions. Clin Dermatol 1993.
  • Vena GA, et al. Occupational contact allergy to benzydamine hydrochloride. Contact Dermatitis 1992.
  • Vena GA, et al. Photocontact allergy due to thiocolchicoside. Contact Dermatitis 1992.
  • Vena GA, et al. Orticaria da farmaci. In: Meneghini CL, Valsecchi R, De Costanza F (eds). Orticaria angioedema. ISED, Brescia, 1991.
  • Vena GA, et al. Patologia cutanea da medicamenti. La Mia Salute 1991.
  • Vena GA, et al. Dermatite da contatto con fenilefrina. Boll Derm Allerg Profes 1991.
  • Vena GA, et al. Dermatite da contatto con minoxidil. Boll Derm Allerg Profes 1991.
  • Vena GA, et al. Spontaneous monitoring of adverse reactions to drugs by Italian dermatologists: a pilot study. Dermatologica 1991.
  • Vena GA, et al. Incidence of Toxic Epidermal Necrolysis in Italy. Arch Dermatol 1990.
  • Vena GA, et al. Dermatite allergica da contatto con ketoconazolo. Boll Derm Allerg Profes 1990.
  • Vena GA, et al. Sorveglianza caso-controllo della syndrome di Stevens-Johnson e della syndrome di Lyell. G It Dermatol Venereol 1989.
  • Vena GA, et al. Allergia da contatto con 8-metossipsoralene. Boll Derm Allerg Profes 1988.
  • Vena GA, et al. Dermatiti iatrogeniche. In Serri F (Ed.). Trattato di Dermatologia. Piccn, Padova, 1988.
  • Vena GA, et al. Contact allergy to antiviral agents. Contact Dermatitis 1986.
  • Vena GA, et al. Allergic contact dermatitis to some medicaments. Contact Dermatitis 1985.
  • Vena GA, et al. Contact allergy to ketoprofen. Contact Dermatitis 1983.
  • Vena GA, et al. Contact dermatitis to scabicides. Contact Dermatitis 1982.
  • Vena GA, et al. Contact dermatitis to benzoyl peroxide. Contact Dermatitis 1982.
Infezioni e MTS
  • Vena GA, Cassano N, et al. Epidemiology of dermatophytoses: Retrospective analysis from 2005 to 2010 and comparison with previous data from 1975. New Microbiol 2012.
  • Vena GA, Cassano N, et al. Recurrence of erythema induratum of Bazin in a patient under chemotherapy for breast cancer. New Microbiol 2011.
  • Vena GA, Cassano N, et al. Oral supplementation with a nutraceutical containing echinacea, methionine and antioxidant/immunostimulating compounds in patients with cutaneous viral warts. G Ital Dermatol Venereol 2011.
  • Vena GA, Cassano N, et al. Zoster... "almost"... sine herpete: Diagnostic utility of real time-polymerase chain reaction. New Microbiol 2010.
  • Vena GA, Cassano N, et al. Acral viral wart showing a parallel ridge pattern on dermatoscopy. Eur J Dermatol 2009.
  • Vena GA, Cassano N, et al. Secondary syphilis with progressive ocular involvement in an immunocompetent patient. Eur J Dermatol 2009.
  • Vena GA, Cassano N, et al. Tinea capitis insorta durante trattamento di lupus eritematoso discoide con tacrolimus unguento. Esp Dermatol 2008.
  • Vena GA, Cassano N, et al. Pubic and vulvar inflammatory tinea due to Trichophyton mentagrophytes. Int J Dermatol 2006.
  • Vena GA, Cassano N, et al. Treatment of recalcitrant cutaneous warts using the 532 nm KTP laser. G Ital Dermatol Venereol 2005.
  • Vena GA, Cassano N, et al. Treatment and prophylaxis of pityriasis versicolor with oral fluconazole. Eur J Inflamm 2003.
  • Vena GA, Cassano N. Cosa c’è di nuovo in terapia: Terapia antivirale. Il Dermatologo 2002.
  • Vena GA, Cassano N. Herpes zoster. Novità in tema di terapia. UTET Periodici, Milano, 2002.
  • Vena GA, Cassano N, et al. Role of Th2 cytokines, RANTES and eotaxin in AIDS-associated eosinophilic folliculitis. Acta Derm Venereol 2001.
  • Vena GA, et al. Evaluation of urethral bacterial flora in asymptomatic drug addict subjects. G Ital Dermatol Venereol 1999.
  • Vena GA, Cassano N, et al. Development of Italian legislation concerning sexually transmitted diseases. Ann It Dermatol Allergol Clin Sper 1997;.
  • Vena GA, et al. Aquarium-borne Mycobacterium marinum occupational skin infection. G Ital Dermatol Venereol 1995.
  • Vena GA, et al. The efficacy of terbinafine in the treatment of tinea corporis. Chron Dermatol 1994.
  • Vena GA, et al. A retrospective study of subjects with syphilis treated with penicillin. Chron Dermatol 1993.
  • Vena GA, et al. Sporotrichoid mycobacteriosis due to Mycobacterium fortuitum. Report of one case and review of literature. G Ital Dermatol Venereol 1992.
  • Vena GA, et al. Sexually transmitted diseases. III. Non-treponemal bacterial infections. Ann Med Nav 1991.
  • Vena GA, et al. Sexually transmitted diseases. V. Protozoal, fungal and parasite infections. Ann Med Nav 1991.
  • Vena GA, et al. Sexually transmitted diseases. IV. Virus infections. Ann Med Nav 1991.
  • Vena GA, et al. Polymorphonuclear cell function impairment in patients with Chlamydia trachomatis urogenital infections. Acta Microbiol Hung 1991.
  • Vena GA, et al. Sexually transmitted diseases. II. Chlamydia and Mycoplasma infections. Ann Med Nav 1991.
  • Vena GA, et al. Urethritis caused by Neisseria meningitidis: A case report. Eur J Epidemiol 1991.
  • Vena GA, et al. Ureaplasma urealyticum: Quantitative cultures in nongonococcal urethritis. G Ital Dermatol Venereol 1991.
  • Vena GA, et al. Micosi cutanee. Recenti acquisizioni. La Mia Salute 1991.
  • Vena GA, et al. Infezioni cutanee professionali da Mycobacterium marinum. Boll Derm Allerg Profes 1990.
  • Vena GA, et al. Una indagine statistica sulla conoscenza delle malattie da contagio sessuale. Ed. Sigma Tau, 1990.
  • Vena GA, et al. Indagini microbiologiche e sierologiche in pazienti con affezioni del tratto uro-genitale. Chron Dermatol 1989.
  • Vena GA, et al. Manifestazioni cutanee associate alla sindrome da immunodeficienza acquisita. Chron Dermatol 1989.
  • Vena GA, et al. Non-gonococcal urethritis and cervicitis from Chlamydia trachomatis: Evaluation by means of chlamydiazine and serology. Boll Ist Sieroter Milan 1988.
  • Vena GA, et al. Indagine sieroepidemiologica sulla infezione da HIV in soggetti osservati presso la Clinica Dermatologica di Bari. Chron Dermatol 1988.
  • Vena GA, et al. Studio sierologico sul ruolo della Chlamydia trachomatis nelle malattie sessualmente trasmesse. Meeting 1988.
  • Vena GA, et al. Gonococcal urethritis and cervicitis: Microbiological investigations. G Ital Dermatol Venereol 1987.
  • Vena GA, et al. Use of chlamydiazyme for the detection of Chlamydia trachomatis in genital infections. Microbiologica 1987.
  • Vena GA, et al. Serological observations in syphilis using the IgM-SPHA test. G Ital Dermatol Venereol 1987.
  • Vena GA, et al. Aetiopathogenetic study of balanoposthitis. G Ital Dermatol Venereol 1985.
  • Vena GA, et al. Survey on the knowledge of the public at large on sexually transmitted diseases in Puglia. G Ital Dermatol Venereol 1984.
  • Vena GA, et al. Efficacy and safety of bifonazole (BAY h 4502) in patients with pityriasis versicolor and tinea cruris. Mykosen 1983.
  • Vena GA, et al. Reazioni sierologiche falsamente positive nei tossicomani. Esp Ospedal 1979.
  • Vena GA, et al. Topical treatment of cutaneous mycosis with econazole. double-blind study with clotrimazole and tolnaftate. G Ital Dermatol Venereol 1979.
Alopecia ed altre malattie di capelli, cuoio capelluto ed annessi ungueali
  • Vena GA, et al. Scalp disorders. J Plastic Dermatol 2010.
  • Vena GA, Cassano N. Treatment of scalp psoriasis with betamethasone dipropionate and calcipotriol two-compound product. Acta Derm Venereol 2007.
  • Vena GA, Cassano N, et al. Diode laser hair removal and isotretinoin therapy. Dermatol Surg 2005.
  • Vena GA, et al. Evaluation of sexual function with an international index of erectile function in subjects taking finasteride for androgenetic alopecia. Arch Dermatol 2004.
  • Vena GA, Cassano N. Valutazione di una lozione cosmetica nell’alopecia androgenetica femminile. Esp Dermatol 2003.
  • Vena GA, Cassano N. Valutazione degli effetti dell’epilazione laser-assistita. Kosmè 2003.
  • Vena GA, Cassano N, et al. Transverse leukonychia in severe hypocalcemia. Eur J Dermatol 2004.
  • Vena GA, Cassano N, et al. Irritant paronychia with onychodystrophy caused by cyanoacrylate nail glue. Contact Dermatitis 2003.
  • Vena GA, Cassano N, et al. Evaluation of the efficacy and tolerability of a dietetic product to normalise sebaceous hypersecretion of the scalp. G Ital Dermatol Venereol 2002.
  • Vena GA, et al. Finasteride (Propecia®) is really effective and safe in the treatment of androgenetic alopecia. Ann It Dermatol Allergol Clin Sper 2001.
  • Vena GA, Cassano N. Impiego del laser a diodi con lunghezza d’onda di 810 nm: consigli pratici ed esperienze preliminari. Cenesthesis, Novembre 1999.
  • Vena GA, et al. Topical finasteride in the treatment of androgenic alopecia. Preliminary evaluations after a 16-month therapy course. J Dermatolog Treat 1997.
  • Vena GA, et al. Evaluation of topical immunotherapy with squaric acid dibutylester, systemic interferon alpha and the combination of both in the treatment of chronic severe alopecia areata. J Dermatolog Treat 1995.
  • Vena GA, et al. New therapeutic schemes in the treatment of onychomycosis. Pharmacol Research 1992.
  • Vena GA, et al. Studio clinico multicentrico sull’impiego del minoxidil in soluzione topica al 2% nel trattamento di pazienti con alopecia androgenetica. G It Dermatol Venereol 1991.
  • Vena GA, et al. The possible immunopathogenetic role of mast cells in alopecia areata. G Ital Dermatol Venereol 1988.
  • Vena GA, et al. Studio di alcune funzioni linfocitarie e monocitarie nell’alopecia areata. Boll Derm Ped 1984.
  • Vena GA, et al. Dermatophytose of the scalp in an adult with partial defect of cell-mediated immunity. Dermatol Clin 1982.
  • Vena GA, et al. Valutazione clinico-sperimentale di una lozione a base di estratto di bile bovina purificato (simile all’acido 3-alfa-7,alfa-diidrossi,5-betacolanico) in soggetti con alopecia androgenetica. La Medicina Estetica 1982.
  • Vena GA, et al. Cell-mediated immunity in alopecia areata. Arch Dermatol Res 1981.
Acne, rosacea, dermatite seborroica e disordini correlati
  • Vena GA, Cassano N, et al. Therapeutic activity of clindamycin/zinc gel alone or combined with a cosmetic cream containing bovine colostrum in patients with mild to moderate inflammatory acne: results from the ZETA project. G Ital Dermatol 2010.
  • Vena GA, Cassano N, et al. Oral terbinafine in the treatment of multi-site seborrhoeic dermatitis: A multicenter, double-blind placebo-controlled study. Int J Immunopathol Pharmacol 2005.
  • Vena GA, Cassano N, et al. Comparison of two different dosing regimens with lymecycline, in association with adapalene, in inflammatory acne. Eur J Inflamm 2005.
  • Vena GA, Cassano N, et al. Treatment of inflammatory acne with a combination therapy with lymecycline and adapalene followed by maintenance treatment with adapalene. Eur J Inflamm 2004.
  • Vena GA, Cassano N, et al. A multicentre open study on the tolerability and efficacy of a cosmetic treatment in mild acne vulgaris during the summer months. Eur J I Inflamm 2003.
  • Vena GA, Cassano N, et al. Treatment of seborrhoeic dermatitis of the scalp with desonide 0.05% solution. Eur J Inflamm 2003.
  • Vena GA, Cassano N, et al. Oral terbinafine for the treatment of seborrheic dermatitis in adults. Int J Dermatol 2002.
  • Vena GA, Cassano N, et al. Treatment of mild to moderate acne vulgaris with adapalene alone or combined with other anti-acne agents. A multicenter open trial. G Ital Dermatol Venereol 2002.
  • Vena GA, Cassano N. La cura dell’acne: linee guida. In: Lotti TM (ed.). L’acne: Nuovi concetti e nuove terapie. UTET Periodici, Milano, 2002.
  • Vena GA, Cassano N, et al. Terbinafina orale nel trattamento della dermatite seborroica: modificazione dei parametri di lipoperossidazione nel sebo. Esp Dermatol 2002.
  • Vena GA, Cassano N. Il metronidazolo topico nel trattamento della rosacea. Dermatologia Ambulatoriale 2000.
  • Vena GA, Cassano N. Systemic isotretinoin treatment in a case of acne associated with autoimmune hepatitis. G Ital Dermatol Venereol 2000.
  • Vena GA, Cassano N. Considerazioni sulla dermatite seborroica dell’adulto. Interaction Srl, Milano, 2000: pagg. 27.
  • Vena GA, Cassano N. Acne e retinoidi. Performance S.r.l., Roma, 2000, pagg. 148.
  • Vena GA, Cassano N. Trattamento della rosacea. Atti degli ‘Incontri di Dermocosmetologia medica e chirurgica. Una nuova pelle per il 2000’. Saint-Vincent, 3-6 Novembre 1999.
  • Vena GA, Cassano N, et al. Infantile eosinophilic folliculitis: A case report. Dermatol Clin 1999.
  • Vena GA, Cassano N, et al. Evaluation of efficacy and tolerability of oral terbinafine in seborrhoeic dermatitis. Ann It Dermatol Allergol Clin Sper 1999.
  • Vena GA, Cassano N. Patogenesi dell'acne. In: L'acne incontra l'esperto. Performance S.r.l., Roma, 1998.
  • Vena GA, Cassano N. Acne: cronologia degli effetti clinici in corso di terapia con isotretinoina sistemica. G Ital Dermatol Venereol 1998.
  • Vena GA, Cassano N, et al. La Lichtena A.I. crema ® nel trattamento della dermatite seborroica infantile. Giorn Int Derm Ped 1996.
  • Vena GA, Cassano N, et al. Treatment of seborrhoeic dermatitis with a cream containing furalglucitole. Ann It Dermatol Clin Sper 1996.
  • Vena GA, et al. Teicoplanin in the treatment of acne: Comparison between two treatment schedules. Ann It Dermatol Clin Sper 1993.
  • Vena GA, et al. Acne. La Mia Salute 1991.
Dermatite atopica, allergia alimentare ed altre allergopatie correlate
  • Vena GA, Cassano N, et al. Dermatite cronica eczematosa delle mani (eczema cronico delle mani). Linee guida e raccomandazioni SIDeMaST. Pacini Editore SpA, Pisa 2011.
  • Vena GA, Cassano N, et al. Occupational respiratory allergy due to Boletus edulis powder. Ann Allergy Asthma Immunol 2008.
  • Vena GA, Cassano N, et al. Clinical evaluation of the efficacy of a barrier cream containing polyvinylpyrrolidone in chronic hand eczema. Eur J Inflamm 2008.
  • Vena GA, Cassano N, et al. Atopic dermatitis and cancer risk. Ann It Dermatol Allergol Clin Sper 2008.
  • Vena GA, Cassano N, et al. Non-allergic occupational asthma because of almond shell dust. Allergy 2008.
  • Vena GA, Cassano N, et al. Allergy to Muscari comosum bulb. Allergy 2007.
  • Vena GA, Cassano N, et al. Infliximab in recalcitrant severe atopic eczema associated with contact allergy. Int J Immunopathol Pharmacol 2006.
  • Vena GA, et al. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis. Br J Dermatol 2005.
  • Vena GA, Cassano N, et al. Hidden allergens in food: General review and update. Ann It Derm Allergol Clin Sper 2004.
  • Vena GA, Cassano N, et al. Risk factors for sensitization to Anisakis simplex: a multivariate statistical evaluation. Int J Immunopathol Pharmacol 2006.
  • Vena GA, Cassano N. Dermatite atopica: Novità in tema di terapia. UTET, Milano 2005, pagg. 1-15.
  • Vena GA, Cassano N. Dermatite atopica: Terapia sistemica. In: Lotti TM, ed. La dermatite atopica. Nuovi concetti e nuove terapie. UTET, Milano, 2003.
  • Vena GA, Cassano N, et al. Topical vitamin E acetate for the treatment of cheilitis: a multicentre experience. Eur J Inflamm 2003.
  • Vena GA, Cassano N. Dermatite atopica ed infezioni: considerazioni cliniche ed epidemiologiche. Eczema Notizie 2003.
  • Vena GA, Cassano N, et al. Evaluation of “steroid sparing” effects of Xanthena® cream in patients with mild to moderate atopic dermatitis. Eur J Inflamm 2003.
  • Vena GA, Cassano N, et al. Acute allergic reactions to Anisakis simplex after ingestion of anchovies. Acta Derm Venereol 2002.
  • Vena GA, Cassano N. Il prurito nella dermatite atopica. Eczema Notizie 2002.
  • Vena GA, Cassano N. Orticaria e atopia. Eczema Notizie 2001.
  • Vena GA, Cassano N. Considerazioni sulla patogenesi della dermatite atopica. Not Allergol 2002.
  • Vena GA, Cassano N, et al. Trattamento della dermatite atopica dell’infanzia con Lichtena â A.I. emulsione: dati preliminari. Dermatologia 2000.
  • Vena GA, Cassano N, et al. Rinite allergica trattata con antiossidanti. Boll Dermatol Allerg Profes 1996.
  • Vena GA, Cassano N, et al. Dermatite atopica: aspetti eziopatogenetici e terapeutici. Giorn Int Derm Ped 1996.
  • Vena GA, et al. Studio eziopatogenetico, clinico e terapeutico della disidrosi. Boll Derm Allerg Profes 1992.
  • Vena GA, et al. Le disidrosi. DERMOtime 1990.
  • Vena GA, et al. Allergia da contatto e reazioni secondarie ad additivi alimentari. G It Dermatol Venereol 1982.
Dermatite da contatto
  • Vena GA, Cassano N, et al. Occupational protein contact dermatitis from wheat flour with IgE reactivity against α-amylase inhibitor. Contact Dermatitis 2012.
  • Vena GA, Cassano N, et al. Airborne allergy to isophoronediamine and epoxy resin. Immunopharmacol Immunotoxicol 2010.
  • Vena GA, Cassano N, et al. Allergic contact dermatitis to propyl gallate and pentylene glycol in an emollient cream. Australas J Dermatol 2010.
  • Vena GA, Cassano N, et al. Occupational allergic contact dermatitis associated with dimethyl fumarate in clothing. Contact Dermatitis 2009.
  • Vena GA, Cassano N, et al. Photoallergic contact dermatitis. G Ital Dermatol Venereol 2009.
  • Vena GA, Cassano N, et al. A matrix assisted laser desorption ionization time-of-flight mass spectrometry investigation to assess the composition of cod liver oil based products which displayed a different in vivo allergenic power. Food Chem Toxicol 2008.
  • Vena GA, Cassano N, et al.Evaluation of the effects of a cosmetic cream on irritant contact dermatitis: results of a multicentre open trial. Eur J Inflamm 2003.
  • Vena GA, Cassano N, et al. Contact sensitization to nickel from rhodium-plated 'nickel-free' earrings. Contact Dermatitis 2002.
  • Vena GA, et al. Mometasone furoate versus betamethasone valerate in the treatment of allergic contact dermatitis. J Eur Acad Dermatol Venereol 1999.
  • Vena GA, et al. Contact allergy to preservatives and perfumed compounds used in skin care products. J Appl Cosmetol 1997.
  • Vena GA, Cassano N, et al. Cement burns in 2 football players. Contact Dermatitis 1997.
  • Vena GA, et al. Pure cocamidopropylbetaine is not the allergen in patients with positive reactions to commercial cocamidopropylbetaine. Contact Dermatitis 1996.
  • Vena GA, et al. Is there any risk of allergic reaction in creno-cosmetology? J Appl Cosmetol 1996.
  • Vena GA, et al. Influence of vehicle on patch test response to nickel sulfate. Contact Dermatitis 1996.
  • Vena GA, et al. Occupational sensitization to epoxy resin and reactive diluents in marble workers. Contact Dermatitis 1996.
  • Vena GA, et al. Contact allergy to impurities in surfactants: Amount, chemical structure and carrier effect in reactions to 3-dimethylaminopropylamine. Contact Dermatitis 1996.
  • Vena GA, et al. Clinico-statistical investigation about cement dermatitis in Italy. G Ital Med Lav 1996.
  • Vena GA, et al. Contact allergy to oleamidopropyl dimethylamine and related substances. Contact Dermatitis 1995.
  • Vena GA, et al. 3-dimethylaminopropylamine: A key substance in contact allergy to cocamidopropylbetaine? Contact Dermatitis 1995.
  • Vena GA, et al. Contact allergy due to methyl glucose dioleate. Contact Dermatitis 1995.
  • Vena GA, et al. Sulfite contact allergy. Contact Dermatitis 1994.
  • Vena GA, et al. Can cyclosporin A help distinguish allergic from irritant patch test reactions? Contact Dermatitis 1994.
  • Vena GA, et al. Mercury exanthem. Contact Dermatitis 1994.
  • Vena GA, et al. Contact irritation associated with airborne contact irritation from mustard gas. Contact Dermatitis 1994.
  • Vena GA, et al. Contact allergy associated with airborne contact allergy from phosphorus sesquisulfide. Am J Contact Dermatitis 1994.
  • Vena GA, et al. Dermatite allergica da contatto non eczematosa. Boll Derm Allerg Profes 1992.
  • Vena GA, et al. The efficacy of immunotherapy in allergic contact dermatitis. Chron Dermatol 1992.
  • Vena GA, et al. Airborne contact dermatitis. Clin Dermatol 1992.
  • Vena GA, et al. Contact stomatitis and cheilitis. Specializzati Oggi - Dermatologia 1992.
  • Vena GA, et al. Allergic contact dermatitis from Capparis spinosa L. applied as wet compresses. Contact Dermatitis 1991.
  • Vena GA, et al. Le fitofotodermatosi da contatto. Boll Derm Allerg Profes 1990.
  • Vena GA, et al. Dermatite da contatto con gas iprite. Boll Derm Allerg Profes 1990.
  • Vena GA, et al. Occupational traumatic lymphedema of the hands. Dermatol Clin 1990.
  • Vena GA, et al. Contact dermatitis from Ficus carica. In: Frosch PJ et al (eds.) Current Topics in Contact Dermatitis. Springer-Verlag, Berlin Heidelberg New York, 1989.
  • Vena GA, et al. Allergia da contatto in sede ano-perineale e genitale. Boll Derm Allerg Profes 1988.
  • Vena GA, et al. Nummular eczema and contact allergy. Boll Derm Allerg Profes 1987.
  • Vena GA, et al. Contact allergy to Kathon® CG. Contact Dermatitis 1987.
  • Vena GA, et al. Psoriasis and contact allergy to propolis. Contact Dermatitis 1987.
  • Vena GA, et al. Contact allergy to Centelase. Contact Dermatitis 1986.
  • Vena GA, et al. Allergic contact dermatitis to colophony in a violoncellist. Contact Dermatitis 1986.
  • Vena GA, et al. Contact allergy to nickel. epidemiological and clinical remarks. G It Dermatol Venereol 1986.
  • Vena GA, et al. Contact dermatitis due to cosmetics. J Appl Cosmetol 1985.
  • Vena GA, et al. Allergic contact cheilitis to guaiazulene. Contact Dermatitis 1984.
  • Vena GA, et al. Eyelid contact dermatitis. Ital Gen Rev Derm 1982.
  • Vena GA, et al. Secretan's syndrome: An artefact oedema of the hand. Contact Dermatitis 1982.
  • Vena GA, et al. Tγ and theophylline-sensitive T lymphocytes in allergic contact dermatitis. Arch Dermatol Res 1982.
  • Vena GA, et al. The active E-rosette test in allergic contact dermatitis. Arch Dermatol Res 1980.
  • Vena GA, et al. Shoe contact dermatitis. Contact Dermatitis 1980.
Vitiligine, lupus eritematoso cutaneo, lichen planus, malattie bollose ed altre malattie autoimmunitarie
  • Vena GA, Cassano N, et al. Cutaneous lupus erythematosus of the scalp treated with methyl-aminolevulinate photodynamic therapy: A case report. G Ital Dermatol Venereol 2012.
  • Vena GA, et al. Evaluation of a new ELISA assay for detection of BP230 autoantibodies in bullous pemphigoid. Ann N Y Acad Sci 2009.
  • Vena GA, Cassano N, et al. Pemphigus vulgaris with circulating anti-desmoglein 3 and anti-BP180 antibodies: A case report and brief review of cases with co-existence of pemphigus vulgaris and bullous pemphigoid. J Biol Regul Homeost Agents 2009.
  • Vena GA Cassano N, et al. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: A review of 110 patients. J Eur Acad Dermatol Venereol 2007.
  • Vena GA, Cassano N, et al. Recalcitrant lesions of pemphigus foliaceous at a surgical site: Successful treatment with tacrolimus 0.1% ointment. Eur J Dermatol 2006.
  • Vena GA, Cassano N, et al. Diffuse cutaneous systemic sclerosis treated with intravenous iloprost. Clin Exp Dermatol 2004.
  • Vena GA, Cassano N, et al. Sindrome orticaria-angioedema, autoimmunità e malattie del connettivo. (in collab. con Galeazzi M, De Pità O, Vena GA). Progr Reumatol 2002.
  • Vena GA, Cassano N, et al. Oral lichen planus: A preliminary clinical study on treatment with tazarotene. Oral Dis 2002.
  • Vena GA, Cassano N, et al. Eosinophilic fasciitis and aplastic anemia: A case report. Chron Dermatol 1997.
  • Vena GA, Cassano N. Vitiligine: Le associazioni cliniche. In: Lotti TM (Ed.) La vitiligine: nuovi concetti e nuove terapie. UTET, Milano, 2000.
  • Vena GA, et al. Concomitant lichen planus and chronic hepatitis after interferon-alpha 2a therapy. Chron Dermatol 1996.
  • Vena GA, et al. Trauma-induced bullous pemphigoid. Ann It Dermatol Clin Sper 1996.
  • Vena GA, et al. Topical 5-fluorouracil in the treatment of discoid lupus erythematosus. Preliminary study over two years. J Dermatolog Treat 1996.
  • Vena GA, ET AL. Annular lichen planus and annular atrophic lichen planus. Ann It Dermatol Clin Sper 1995.
  • Vena GA, et al. IL-1alpha, IL-6 and TNF-alpha in cutaneous lesions of lupus erythematosus are inhibited by topical application of calcipotriol. Int J Immunopathol Pharmacol 1995.
  • Vena GA, et al. Bullous pemphigoid on actinic elastosis following an allergic photocontact dermatitis. G Ital Dermatol Venereol 1995.
  • Vena GA, et al. Treatment of some photodermatoses and cutaneous lupus erythematosus with a cream containing furalglucitole. Ann It Dermatol Clin Sper 1995.
  • Vena GA, et al. Lichen planus and hepatitis C virus. G Ital Dermatol Venereol 1994.
  • Vena GA, et al. Feasibility of a registry of pemphigus in Italy: Two years experience. Int J Dermatol 1993.
  • Vena GA, et al. Epidemiological evidence of the association between lichen planus and two immune-related diseases. Alopecia areata and ulcerative colitis. Arch Dermatol 1991.
  • Vena GA, et al. Lichen planus and liver diseases: a multicenter case-control study. Br Med J 1990.
  • Vena GA, et al. Lo studio sul lichen planus condotto dal GISED. Risultati, implicazioni per la pratica clinica, prospettive. G It Dermatol Venereol 1990.
  • Vena GA, et al. Effect of oral isotretinoin in cutaneous lupus erythematosus. G Ital Dermatol Venereol 1989.
  • Vena GA, et al. Il GISED e il progetto pilota sull’eziologia del lichen planus. G It Dermatol Venereol 1987.
  • Vena GA, et al. Persistent acantholytic dermatosis. Dermatol Clin 1984.
  • Vena GA, et al. Funzioni monocitarie nel lupus eritematoso cutaneo. Immunologia, Attualità e prospettive. Il Pensiero Scientifico Editore, Roma, 1983.
  • Vena GA, et al. Sottopopolazioni linfocitarie T e fattori soppressivisolubili nel lupus eritematoso cutaneo. Immunologia, Attualità e prospettive. Il Pensiero Scientifico Editore, Roma, 1983.
Note speciali di farmacologia e terapia in dermatologia
  • Vena GA, Cassano N. The effects of alcohol on the metabolism and toxicology of anti-psoriasis drugs. Exp Opin Drug Metabol Toxicol 2012.
  • Vena GA, Cassano N, et al. Antiinflammatory effects of H1-antihistamines: Clinical and immunological relevance. Curr Pharm Des 2008.
  • Vena GA, Cassano N, et al. Omalizumab: A novel therapeutic tool in allergological dermatology? Annali Italiani di Dermatologia Allergologica Clinica e Sperimentale 2008.
  • Vena GA, Cassano N. La ciclosporina. Psoriasis 2007.
  • Vena GA, Cassano N. Terapia steroidea topica in dermatologia: cosa non fare; come e quando usarla. Dermatologia & Pratica medica 2003.
  • Vena GA, Cassano N. Tacrolimus unguento: profilo farmacologico e potenziale terapeutico in dermatologia. Medical International Review 2003.
  • Vena GA, Cassano N, et al. Adapalene: Pharmacological and therapeutic features. G Ital Dermatol Venereol 2003.
  • Vena GA, Cassano N, et al. Zinc nutritive and skin: An overview. J Appl Cosmetol 2002.
  • Vena GA, Cassano N, et al. Cheilitis granulomatosa: A case report treated with cyclosporin A. Derm Clin 2002.
  • Vena GA, Cassano N, et al. Cyclosporin A in chronic idiopathic urticaria: An update. (in collab. con D’Argento V, Vena GA). Int J Immunopathol Pharmacol 2002.
  • Vena GA, Cassano N, et al. Gli antistaminici: servono solo per contrastare gli effetti dell’istamina? In: Lotti TM (Ed.) Modelli di infiammazione cutanea. Prospettive di interazioni terapeutiche. UTET, Milano, 2001.
  • Vena GA, Cassano N, et al. Indicazioni mediche per l’acido glicolico. La pelle 2001.
  • Vena GA, Cassano N, et al. Role of nimesulide in dermatology. Ann It Derm Allergol Clin Sper 2001.
  • Vena GA, Cassano N. Can we still suggest the topical cyclosporin treatment in cutaneous disorders? J Eur Acad Dermatol Venereol 2001.
  • Vena GA, Cassano N, et al. Biological activity of histamine and pharmacological profile of antihistamines used in dermatology. Ann It Dermatol Allergol Clin Sper 2000.
  • Vena GA, Cassano N. Efficacy of oral isotretinoin: Dosage problem and management of possible recurrence. G Ital Dermatol Venereol 2000.
  • Vena GA, Cassano N, et al. Tazarotene. Esperienza italiana. Farmacodinamica. G Ital Dermatol Venereol 1999.
  • Vena GA, Cassano N. Isotretinoina sistemica e ghiandola sebacea (in collab. con Vena GA). G Ital Dermatol Venereol 1999.
  • Vena GA, Cassano N. Isotretinoina sistemica e gravidanza (in collab. con Vena GA). G Ital Dermatol Venereol 1999.
  • Vena GA, Cassano N. Isotretinoina sistemica: azione sulla cheratinizzazione follicolare (in collab. con Vena GA). G Ital Dermatol Venereol 1999.
  • Vena GA, Cassano N. Immunosuppressive therapy in cutaneous vasculitis. Clin Dermatol 1999.
  • Vena GA, Cassano N, et al. Peeling agents: Toxicological and allergological aspects. J Eur Acad Dermatol Venereol 1999.
  • Vena GA, Cassano N, et al. Necrobiosis lipoidica treated with cyclosporin A. Derm Clin 1998.
  • Vena GA, Cassano N, et al. Management of some inflammatory dermatoses with a cosmetic preparation containing antioxidant/antiinflammatory agents. G Ital Dermatol Venereol 1998.
  • Vena GA, et al. Treatment of pyoderma gangrenosum with nimesulide. Ann It Dermatol Clin Sper 1997.
  • Vena GA, Cassano N, et al. Oral retinoids in the treatment of pityriasis lichenoides. J Dermatolog Treat 1997.
  • Vena GA, et al. Cyclosporin A in the treatment of necrobiosis lipoidica diabeticorum. J Dermatolog Treat 1997.
  • Vena GA, Cassano N, et al. The mechanism of action of cyclosporin A in the treatment of chronic urticaria. Sem Clin Immunol 1997.
  • Vena GA, Cassano N, et al. Nimesulide in dermatology. Medit J Surg Med 1996.
  • Vena GA, et al. Treatment of Sweet's syndrome with nimesulide. Ann It Dermatol Allergol Clin Sper 1996.
  • Vena GA, et al. Treatment of some neutrophil mediated skin disorders by cyclosporin A. Ann It Dermatol Allergol Clin Sper 1995.
  • Vena GA, et al. Lichen myxoedematosus treated with cyclosporin A: A new therapeutic approach for a disabling dermatosis. J Dermatolog Treat 1995.
  • Filotico R, et al. Cyclosporine in the treatment of generalized granuloma annulare. J Am Acad Dermatol 1994.
  • Vena GA, et al. Reticuloide attinico e trattamento con ciclosporina A. Studio clinico ed immunologico di 2 casi. Boll Derm Allerg Profes 1989.
Miscellanea di dermatologia clinica ed altri argomenti generali
  • Vena GA, Cassano N, et al. Granulomatous skin lesions in a renal transplant patient. Clin Exp Med 2012.
  • Vena GA, Cassano N, et al. Coelenterates and the skin. G It Dermatol Venereol 2006.
  • Vena GA, Cassano N, et al. Eczematizzazione. In: Lotti TM, ed. Ulcerazione e cicatrizzazione cutanea. Nuovi concetti e nuove terapie. UTET, Milano, 2005.
  • Vena GA, Cassano N. Inherited hypomelanotic disorders. (in collab. con Vena GA). In: Lotti T, Hercogová J. Vitiligo – Problems and Solutions. Marcel Dekker, Inc, New York, Basel, 2004.
  • Vena GA, Cassano N, et al. Lupus erythematosus-like lesions in a carrier of X-linked chronic granulomatous disease: A case report and personal considerations. Int J Dermatol 2004.
  • Vena GA, Cassano N, et al. Mastociti e basofili: modelli di flogosi e possibili interazioni farmacologiche. In: Lotti TM (Ed.) Modelli di infiammazione cutanea. Prospettive di interazioni terapeutiche. UTET, Milano, 2001.
  • Vena GA, Cassano N, et al. Dermatiti da fisalie e da idroidi. In: Veraldi S, Caputo R (eds). Dermatologia di importazione (seconda edizione). Paletto Editore, Gaggiano (MI), 2000.
  • Vena GA, Cassano N, et al. Dermatiti da echinodermi. In: Veraldi S, Caputo R (eds). Dermatologia di importazione (seconda edizione). Paletto Editore, Gaggiano (MI), 2000.
  • Vena GA, Cassano N, et al. Prototecosi. In: Veraldi S, Caputo R (eds). Dermatologia di importazione (seconda edizione). Paletto Editore, Gaggiano (MI), 2000.
  • Vena GA, et al. Validation of QUAVIDERM, an instrument to measure quality of Italian life in dermatology. Ann It Dermatol Allergol Clin Sper 1999.
  • Vena GA, et al. Dermatologia professionale e ambientale. ISED, Brescia, 1999 Vol. 2 e Vol. 3
  • Vena GA, et al. QUAVIDERM: A questionnaire for the evaluation of the Italian quality of life in dermatology. Ann It Dermatol Allergol Clin Sper 1997.
  • Vena GA, et al. Dermatologia professionale e ambientale. ISED, Brescia, 1997 Vol. 1
  • Vena GA, Cassano N, et al. Flogosi, stress ossidativo e immunita' nella patologia cutanea. Boll Dermatol Allerg Profes 1996.
  • Vena GA, et al. Dermatologia termale. La Mia Salute 1992.
  • Vena GA, et al. Dermatologia da fauna marina. Primo soccorso terapeutico. La Mia Salute 1991.
  • Vena GA, et al. Dermatologia acquatica. Ed. Lepetit, Milano, 1985, pagg. 415.
  • Vena GA, et al. Manuale di Dermatologia. Società Editrice Universo, Roma 1979, pagg. 321.
  • Vena GA, et al. In tema di immunità cellulo-mediata nei politossicomani. Esp Ospedal 1979.
  • Vena GA, et al. Nozioni di Dermatologia. Società Editrice Universo, Roma 1979, pagg. 321.

Studio di Dermatologia e Venereologia
Prof. Gino Antonio Vena e Dott.ssa Nicoletta Cassano

Studio di Bari:
Via Fanelli, 206/16
70125 BARI
tel: +39.080.50.25.794
Studio di Barletta:
Via Renato Coletta, 32
76121 - BARLETTA
tel: +39.0883.53.34.34
Prof. Vena P.IVA 02447960721
Dott.ssa Cassano P.IVA 05235720728